The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

In his interview with Easton Jr., Dawkins discussed representing Boehringer & Lilly’s It Takes 2 health initiative, spreading ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

We recently compiled a list of the Tech Billionaire Chase Coleman’s Top 10 Stock Picks. In this article, we are going to take ...

Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets ...

Hanukkah, Judaism's eight-day Festival of Lights, begins this year on Christmas Day, which has only happened four times since ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Action superstar Sylvester Stallone pulled plans for a proposed seaweed barrier next to his home, after hearing concerns from ...

A driver involved in a tragic hit-and-run incident in Phuket turned himself into the police. Police confirmed that the driver will face charges for his actions following the fatal accident that ...